Category: Antibody Technologies
Global Antibody Technologies
-
Global Monoclonal Antibody Diagnostic Reagents Competitive Landscape Professional Research Report 2024
... are designed to detect and identify specific antigens, molecules, or markers in biological samples for diagnostic purposes. Monoclonal antibody diagnostic reagents play a crucial role in various medical fields, including immunology, microbiology, hematology, and pathology. ... Read More
-
Biopharmaceuticals Market by Product Type (Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors), Services (Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, Laboratory Testing), Raw Material Type, Application - Global Forecast 2024-2030
... The Biopharmaceuticals Market size was estimated at USD 574.04 billion in 2023 and expected to reach USD 627.19 billion in 2024, at a CAGR 9.74% to reach USD 1,100.51 billion by 2030. Biopharmaceuticals, also known ... Read More
-
Antibody Drug Conjugate Market by Mechanism of Action (CD30 Antibodies, ErbB2 Antibodies), Drugs (Adcetris, Blenrep, Enhertu), Technology, Indication, End User - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 6.48 billion in 2024, at a CAGR 16.12% to reach USD 15.96 billion by 2030. The antibody drug conjugate (ADC) includes developing, manufacturing, and commercializing therapeutic molecules ... Read More
-
Research Antibodies Market by Indication (Immunology, Infectious Diseases, Neurobiology), Operation (Drug Development, Genomics, Proteomics), Product, Source, Technology, Type, End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.79 billion in 2024, at a CAGR 8.43% to reach USD 11.05 billion by 2030. The market for research antibodies refers to the global industry that revolves around ... Read More
-
Gene Therapy Market by Type (Antigen Gene Therapy, Cancer Gene Therapy, Cytokine Gene Therapy), Vector Type (Non-viral Vectors, Viral Vectors), Application - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 7.05 billion in 2024, at a CAGR 27.15% to reach USD 30.48 billion by 2030. Gene therapy is a medical procedure that introduces, alters, or corrects genetic ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 36.58 billion in 2024, at a CAGR 10.64% to reach USD 67.22 billion by 2030. Generic injectables are non-branded pharmaceuticals that are administered by injection and have the same ... Read More
-
Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2024-2030
... 16.54 billion in 2023 and expected to reach USD 18.55 billion in 2024, at a CAGR 12.02% to reach USD 36.62 billion by 2030. Research antibodies are proteins produced by the body's immune system to ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological treatments ... Read More
-
HIV Vaccines Market by Phase (Phase I, Phase II, Phase III), Category (Preventive Vaccines, Therapeutic Vaccines), Antibodies, End Users - Global Forecast 2024-2030
... 2023 and expected to reach USD 940.05 million in 2024, at a CAGR 12.88% to reach USD 1,951.26 million by 2030. The HIV vaccine pertains to the research, development, and commercialization of vaccines that are ... Read More
-
Skeletal Dysplasia Drugs Market - By Dysplasia Type (Morquio A Syndrome, X-linked Hypophosphatemia, Hypophosphatasia, Achondroplasia), Treatment (Enzyme Replacement Therapy, Human Monoclonal Antibody), Distribution Channel – Global Forecast (2024 – 2032)
... is projected to witness 4.2% CAGR between 2024 and 2032 driven by the increasing prevalence and diagnosis of skeletal dysplasia. As per reports, non-lethal skeletal dysplasia occurs in approximately 1 in 26,000 to 1 in ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032
... By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032 The global cancer immunotherapy market size is expected to reach USD 261.39 billion by 2032 according to a new study by Polaris ... Read More
-
Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2024 - 2032
... Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2024 - 2032 The global active pharmaceutical ingredient (API) market size is expected to ... Read More
-
Global Protein Therapeutics Market 2024-2028
... report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Antibody Drug Conjugates Contract Manufacturing Market Forecast 2024-2032
... market growth: the rising demand for targeted therapies, the growing inclination towards contract manufacturing companies as an economical choice, the surging global cancer incidence, and advancements in drug conjugation technologies. MARKET INSIGHTS The global antibody ... Read More
-
Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029
... market is projected to reach USD 238.3 billion by 2029 from USD 163.5 billion in 2024, at a CAGR of 7.8% during the forecast period of 2024 to 2029. The growth of this market can ... Read More
-
Protein A Resin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... reach USD 1.78 billion by 2029, growing at a CAGR of 8.69% during the forecast period (2024-2029). According to Cancer Facts and Figures 2023 by the American Cancer Society, the number of new cancer cases ... Read More
-
Global Immunoglobulin Products Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Legionella Testing Market: Analysis By Type (Culture Methods, Polymerase Chain Reaction Testing, Urinary Antigen Tests, Direct Fluorescent Antibody Tests, and Others), By Application (Water Testing, In-vitro Diagnostics Testing, and Other Applications), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... and Trends with Impact of COVID-19 and Forecast up to 2029 Legionella is a bacteria that cause legionellosis, a type of pneumonia. Legionella testing is essential for assessing the risk of Legionnaires' disease outbreaks & ... Read More
-
2024 Global Forecast for Biosimilar Monoclonal Antibodies Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Plasma Protein Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Global Antibody Drug Conjugates Contract Manufacturing Databank Market Report.pdf
... of 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR ... Read More
-
Global Antibody Drug Conjugate Databank Market Report
... 2023 to 2031. Blood Cancer segment is expected to be the highest contributor to this market, with $2,539.5 Million in 2022, and is anticipated to reach $4,905.2 Million by 2031, registering a CAGR of 7.63%. ... Read More
-
Global Mononucleosis Diagnostic Databank Market Report
... 2031. Complete Blood Count Test segment is expected to be the highest contributor to this market, with $1,138.6 Million in 2022, and is anticipated to reach $1,210.1 Million by 2031, registering a CAGR of 0.71%. ... Read More
Research Assistance
